| 0 |
TRIPLE A SYNDROME |
1 |
0.5000 |
| 1 |
OSTEOFIBROMA |
1 |
0.3333 |
| 2 |
INTESTINAL NEURONAL DYSPLASIA |
1 |
0.3333 |
| 3 |
TESTICULAR APPENDAGE TORSION |
1 |
0.2500 |
| 4 |
AURAL POLYP |
5 |
0.1190 |
| 5 |
SECRETORY ADENOMA OF PITUITARY |
1 |
0.0909 |
| 6 |
CAECUM OPERATION |
1 |
0.0833 |
| 7 |
RADIOALLERGOSORBENT TEST POSITIVE |
1 |
0.0769 |
| 8 |
LACTASE DEFICIENCY |
1 |
0.0714 |
| 9 |
OVARIAN GRANULOSA CELL TUMOUR |
2 |
0.0714 |
| 10 |
IMPLANT SITE PAPULES |
1 |
0.0667 |
| 11 |
CARTILAGE HYPERTROPHY |
1 |
0.0588 |
| 12 |
OVARIAN GRANULOSA-THECA CELL TUMOUR |
2 |
0.0571 |
| 13 |
MULTIPLE ENDOCRINE NEOPLASIA |
1 |
0.0526 |
| 14 |
EYEGLASSES THERAPY |
1 |
0.0500 |
| 15 |
RATHKE'S CLEFT CYST |
1 |
0.0500 |
| 16 |
CARTILAGE NEOPLASM |
1 |
0.0476 |
| 17 |
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION |
1 |
0.0476 |
| 18 |
BILATERAL BREAST BUDS |
1 |
0.0455 |
| 19 |
ADENOIDAL HYPERTROPHY |
12 |
0.0435 |
| 20 |
SPLENIC VARICES |
1 |
0.0417 |
| 21 |
INFERIORITY COMPLEX |
1 |
0.0333 |
| 22 |
STERNOTOMY |
1 |
0.0333 |
| 23 |
ACTH STIMULATION TEST ABNORMAL |
1 |
0.0323 |
| 24 |
INSULIN RESISTANCE SYNDROME |
1 |
0.0303 |
| 25 |
TONSILLAR HYPERTROPHY |
31 |
0.0287 |
| 26 |
MANUFACTURING PRODUCTION ISSUE |
1 |
0.0250 |
| 27 |
DIABETES MELLITUS MANAGEMENT |
1 |
0.0250 |
| 28 |
TESTICULAR TORSION |
2 |
0.0244 |
| 29 |
AUTOSOMAL CHROMOSOME ANOMALY |
1 |
0.0217 |
| 30 |
NASAL TURBINATE HYPERTROPHY |
4 |
0.0213 |
| 31 |
DYSPLASTIC NAEVUS SYNDROME |
1 |
0.0213 |
| 32 |
ECHINOCOCCIASIS |
1 |
0.0208 |
| 33 |
ENCOPRESIS |
3 |
0.0200 |
| 34 |
OPTIC DISCS BLURRED |
1 |
0.0200 |
| 35 |
TYMPANIC MEMBRANE HYPERAEMIA |
1 |
0.0185 |
| 36 |
CYSTIC LUNG DISEASE |
1 |
0.0182 |
| 37 |
OESOPHAGOGASTRIC FUNDOPLASTY |
2 |
0.0180 |
| 38 |
VOLVULUS OF SMALL BOWEL |
2 |
0.0179 |
| 39 |
ADENOTONSILLECTOMY |
3 |
0.0168 |
| 40 |
EPIPHYSIOLYSIS |
3 |
0.0165 |
| 41 |
RETINOPATHY PROLIFERATIVE |
2 |
0.0160 |
| 42 |
CSF WHITE BLOOD CELL COUNT POSITIVE |
1 |
0.0149 |
| 43 |
KARYOTYPE ANALYSIS ABNORMAL |
1 |
0.0139 |
| 44 |
LACK OF ADMINISTRATION SITE ROTATION |
1 |
0.0133 |
| 45 |
EXCESSIVE EXERCISE |
1 |
0.0132 |
| 46 |
OVARIAN TORSION |
1 |
0.0120 |
| 47 |
HETEROPHORIA |
1 |
0.0112 |
| 48 |
NEUTRALISING ANTIBODIES |
1 |
0.0112 |
| 49 |
MALOCCLUSION |
2 |
0.0108 |
| 50 |
BLOOD GROWTH HORMONE ABNORMAL |
1 |
0.0108 |
| 51 |
ADENOMATOUS POLYPOSIS COLI |
1 |
0.0108 |
| 52 |
GASTRITIS VIRAL |
1 |
0.0106 |
| 53 |
CARDIAC VENTRICULAR DISORDER |
3 |
0.0106 |
| 54 |
ACROMEGALY |
2 |
0.0094 |
| 55 |
OTITIS MEDIA CHRONIC |
3 |
0.0093 |
| 56 |
ANOREXIA NERVOSA |
2 |
0.0091 |
| 57 |
BONE LESION EXCISION |
1 |
0.0086 |
| 58 |
TONGUE BLACK HAIRY |
1 |
0.0084 |
| 59 |
CONGENITAL NAEVUS |
1 |
0.0083 |
| 60 |
BLOOD KETONE BODY PRESENT |
1 |
0.0083 |
| 61 |
ACANTHOSIS NIGRICANS |
1 |
0.0082 |
| 62 |
SIGHT DISABILITY |
1 |
0.0077 |
| 63 |
PRECOCIOUS PUBERTY |
3 |
0.0074 |
| 64 |
NOSE DEFORMITY |
2 |
0.0073 |
| 65 |
ENLARGED CLITORIS |
1 |
0.0072 |
| 66 |
BENIGN INTRACRANIAL HYPERTENSION |
9 |
0.0072 |
| 67 |
HYPERSPLENISM |
2 |
0.0071 |
| 68 |
OVARIAN ADENOMA |
1 |
0.0071 |
| 69 |
CHEST WALL HAEMATOMA |
1 |
0.0066 |
| 70 |
OSTEOCHONDROSIS |
5 |
0.0066 |
| 71 |
SPIDER NAEVUS |
1 |
0.0065 |
| 72 |
VISUAL ACUITY TESTS ABNORMAL |
1 |
0.0064 |
| 73 |
DEVICE EXTRUSION |
1 |
0.0063 |
| 74 |
VAGINAL ABSCESS |
1 |
0.0061 |
| 75 |
ADNEXAL TORSION |
1 |
0.0061 |
| 76 |
INJECTION SITE HYPERTROPHY |
1 |
0.0060 |
| 77 |
ADENOIDAL DISORDER |
1 |
0.0058 |
| 78 |
ABDOMINOPLASTY |
1 |
0.0058 |
| 79 |
OVERGROWTH BACTERIAL |
1 |
0.0056 |
| 80 |
GROWING PAINS |
1 |
0.0056 |
| 81 |
BIRTH MARK |
1 |
0.0056 |
| 82 |
LIGAMENT OPERATION |
1 |
0.0054 |
| 83 |
EOSINOPHILIC OESOPHAGITIS |
2 |
0.0054 |
| 84 |
LIMB TRAUMATIC AMPUTATION |
1 |
0.0053 |
| 85 |
REFRACTION DISORDER |
1 |
0.0053 |
| 86 |
URETERIC DILATATION |
1 |
0.0051 |
| 87 |
GROWTH FAILURE |
1 |
0.0051 |
| 88 |
DIET NONCOMPLIANCE |
1 |
0.0050 |
| 89 |
APOPTOSIS |
1 |
0.0048 |
| 90 |
BONE DEVELOPMENT ABNORMAL |
1 |
0.0047 |
| 91 |
LIPOHYPERTROPHY |
2 |
0.0046 |
| 92 |
CONDUCTIVE DEAFNESS |
1 |
0.0045 |
| 93 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
2 |
0.0045 |
| 94 |
MUSCLE HYPERTROPHY |
1 |
0.0044 |
| 95 |
ADENOIDECTOMY |
1 |
0.0044 |
| 96 |
SNORING |
11 |
0.0043 |
| 97 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
5 |
0.0043 |
| 98 |
TYMPANIC MEMBRANE DISORDER |
1 |
0.0043 |
| 99 |
TOXOPLASMOSIS |
3 |
0.0042 |
| 100 |
DRUG ADMINISTERED IN WRONG DEVICE |
2 |
0.0041 |
| 101 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0041 |
| 102 |
VULVAL ABSCESS |
1 |
0.0040 |
| 103 |
ENTEROBACTER SEPSIS |
1 |
0.0040 |
| 104 |
PAPILLOEDEMA |
12 |
0.0039 |
| 105 |
GROWTH RETARDATION |
8 |
0.0038 |
| 106 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
4 |
0.0038 |
| 107 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
3 |
0.0037 |
| 108 |
LYMPHOID TISSUE HYPERPLASIA |
1 |
0.0037 |
| 109 |
THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0036 |
| 110 |
SOFT TISSUE SWELLING |
1 |
0.0035 |
| 111 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
1 |
0.0035 |
| 112 |
LIMB ASYMMETRY |
2 |
0.0034 |
| 113 |
OVARIAN ENLARGEMENT |
1 |
0.0033 |
| 114 |
POLYCYSTIC OVARIES |
3 |
0.0032 |
| 115 |
BLOOD INSULIN INCREASED |
1 |
0.0030 |
| 116 |
INTRACRANIAL PRESSURE INCREASED |
11 |
0.0030 |
| 117 |
OPEN FRACTURE |
1 |
0.0029 |
| 118 |
IGA NEPHROPATHY |
2 |
0.0028 |
| 119 |
LOW SET EARS |
1 |
0.0027 |
| 120 |
BODY MASS INDEX INCREASED |
2 |
0.0026 |
| 121 |
AMBLYOPIA |
1 |
0.0026 |
| 122 |
ENDOMETRIAL ADENOCARCINOMA |
1 |
0.0026 |
| 123 |
PROCEDURAL VOMITING |
1 |
0.0026 |
| 124 |
HYPERTROPHY |
1 |
0.0025 |
| 125 |
ESCHERICHIA TEST POSITIVE |
2 |
0.0025 |
| 126 |
HYDROCELE |
2 |
0.0024 |
| 127 |
OTITIS EXTERNA |
2 |
0.0024 |
| 128 |
BUNION OPERATION |
1 |
0.0024 |
| 129 |
FEBRILE CONVULSION |
2 |
0.0024 |
| 130 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
1 |
0.0023 |
| 131 |
METAL POISONING |
1 |
0.0022 |
| 132 |
HYPERTROPHIC CARDIOMYOPATHY |
2 |
0.0021 |
| 133 |
MELANOCYTIC NAEVUS |
6 |
0.0021 |
| 134 |
THYROXINE FREE INCREASED |
1 |
0.0021 |
| 135 |
OTITIS MEDIA |
5 |
0.0021 |
| 136 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0020 |
| 137 |
KETOSIS |
1 |
0.0020 |
| 138 |
SICKLE CELL ANAEMIA |
1 |
0.0019 |
| 139 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0018 |
| 140 |
TESTICULAR ATROPHY |
1 |
0.0018 |
| 141 |
NASAL OEDEMA |
2 |
0.0018 |
| 142 |
AXONAL NEUROPATHY |
1 |
0.0017 |
| 143 |
SPINAL FUSION SURGERY |
4 |
0.0017 |
| 144 |
CULTURE URINE POSITIVE |
2 |
0.0017 |
| 145 |
FACIAL ASYMMETRY |
1 |
0.0017 |
| 146 |
INJECTION RELATED REACTION |
1 |
0.0017 |
| 147 |
BREATH ODOUR |
3 |
0.0017 |
| 148 |
SPLENIC INFARCTION |
2 |
0.0017 |
| 149 |
GINGIVAL HYPERPLASIA |
1 |
0.0017 |
| 150 |
SELECTIVE EATING DISORDER |
1 |
0.0016 |
| 151 |
ADENOMA BENIGN |
1 |
0.0016 |
| 152 |
FIBROMA |
1 |
0.0016 |
| 153 |
INJECTION SITE MACULE |
1 |
0.0016 |
| 154 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0016 |
| 155 |
HYPERPLASIA |
1 |
0.0015 |
| 156 |
HYPOGLYCAEMIA |
54 |
0.0015 |
| 157 |
HYPERMETROPIA |
1 |
0.0015 |
| 158 |
HEPATIC INFECTION |
1 |
0.0015 |
| 159 |
MUSCLE SWELLING |
1 |
0.0015 |
| 160 |
PYLORIC STENOSIS |
1 |
0.0015 |
| 161 |
AORTIC DILATATION |
1 |
0.0014 |
| 162 |
VOLVULUS |
2 |
0.0014 |
| 163 |
ULNA FRACTURE |
1 |
0.0014 |
| 164 |
T-CELL LYMPHOMA |
1 |
0.0014 |
| 165 |
INJECTION SITE HYPERSENSITIVITY |
2 |
0.0014 |
| 166 |
SKIN TEST POSITIVE |
1 |
0.0014 |
| 167 |
DYSPLASIA |
1 |
0.0014 |
| 168 |
HYPOGLYCAEMIC SEIZURE |
1 |
0.0013 |
| 169 |
PNEUMONIA STREPTOCOCCAL |
1 |
0.0013 |
| 170 |
RHINOVIRUS INFECTION |
2 |
0.0013 |
| 171 |
INJECTION SITE URTICARIA |
19 |
0.0013 |
| 172 |
GINGIVAL HYPERTROPHY |
1 |
0.0013 |
| 173 |
CARDIAC HYPERTROPHY |
1 |
0.0013 |
| 174 |
EPIDIDYMITIS |
1 |
0.0013 |
| 175 |
PHARYNGEAL ERYTHEMA |
2 |
0.0012 |
| 176 |
VITH NERVE PARALYSIS |
1 |
0.0012 |
| 177 |
TONSILLAR DISORDER |
1 |
0.0012 |
| 178 |
HYPOVITAMINOSIS |
1 |
0.0012 |
| 179 |
ENDOCRINE DISORDER |
1 |
0.0012 |
| 180 |
LIP ULCERATION |
1 |
0.0012 |
| 181 |
LIP DISCOLOURATION |
1 |
0.0012 |
| 182 |
RADIUS FRACTURE |
2 |
0.0012 |
| 183 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0012 |
| 184 |
PRODUCT SUPPLY ISSUE |
2 |
0.0011 |
| 185 |
SOFT TISSUE DISORDER |
1 |
0.0011 |
| 186 |
PHARYNGITIS STREPTOCOCCAL |
7 |
0.0011 |
| 187 |
ADNEXA UTERI PAIN |
1 |
0.0010 |
| 188 |
STRABISMUS |
2 |
0.0010 |
| 189 |
SCOLIOSIS |
4 |
0.0010 |
| 190 |
CALCULUS URINARY |
1 |
0.0009 |
| 191 |
FACIAL PALSY |
2 |
0.0009 |
| 192 |
RETINAL OEDEMA |
1 |
0.0009 |
| 193 |
HAIR TEXTURE ABNORMAL |
10 |
0.0009 |
| 194 |
PAPILLARY THYROID CANCER |
1 |
0.0009 |
| 195 |
JAW DISORDER |
4 |
0.0009 |
| 196 |
COMPLEX PARTIAL SEIZURES |
1 |
0.0009 |
| 197 |
GAZE PALSY |
1 |
0.0009 |
| 198 |
TONSILLECTOMY |
1 |
0.0009 |
| 199 |
WEIGHT ABNORMAL |
1 |
0.0009 |
| 200 |
PITUITARY TUMOUR BENIGN |
1 |
0.0009 |
| 201 |
BONE MARROW TRANSPLANT |
1 |
0.0008 |
| 202 |
OPTIC NERVE DISORDER |
1 |
0.0008 |
| 203 |
LYMPH NODE PAIN |
1 |
0.0008 |
| 204 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0008 |
| 205 |
MASTITIS |
1 |
0.0008 |
| 206 |
INSULIN RESISTANCE |
1 |
0.0008 |
| 207 |
NASAL SEPTUM DEVIATION |
1 |
0.0008 |
| 208 |
INDURATION |
1 |
0.0008 |
| 209 |
NON-HODGKIN'S LYMPHOMA |
1 |
0.0008 |
| 210 |
DRUG LEVEL BELOW THERAPEUTIC |
2 |
0.0008 |
| 211 |
MITRAL VALVE DISEASE |
1 |
0.0007 |
| 212 |
BLOOD GLUCOSE DECREASED |
26 |
0.0007 |
| 213 |
HUNGER |
5 |
0.0007 |
| 214 |
WEIGHT GAIN POOR |
1 |
0.0007 |
| 215 |
SKIN INDURATION |
1 |
0.0007 |
| 216 |
BACTERIAL TEST POSITIVE |
1 |
0.0007 |
| 217 |
MIDDLE EAR EFFUSION |
1 |
0.0007 |
| 218 |
SLEEP APNOEA SYNDROME |
9 |
0.0007 |
| 219 |
CEREBRAL ATROPHY |
2 |
0.0007 |
| 220 |
GOITRE |
2 |
0.0007 |
| 221 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0007 |
| 222 |
SCREAMING |
3 |
0.0006 |
| 223 |
EAR PRURITUS |
1 |
0.0006 |
| 224 |
INCREASED APPETITE |
7 |
0.0006 |
| 225 |
FEAR OF INJECTION |
2 |
0.0006 |
| 226 |
INJECTION SITE INDURATION |
6 |
0.0006 |
| 227 |
ANIMAL BITE |
1 |
0.0006 |
| 228 |
EXPIRED DRUG ADMINISTERED |
3 |
0.0006 |
| 229 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0006 |
| 230 |
PRODUCT CONTAMINATION |
1 |
0.0006 |
| 231 |
HYPOGLYCAEMIC UNCONSCIOUSNESS |
1 |
0.0006 |
| 232 |
TONSILLITIS |
2 |
0.0006 |
| 233 |
INJECTION SITE VESICLES |
2 |
0.0006 |
| 234 |
VOMITING PROJECTILE |
1 |
0.0006 |
| 235 |
NASAL DISORDER |
1 |
0.0006 |
| 236 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
2 |
0.0006 |
| 237 |
HORDEOLUM |
1 |
0.0006 |
| 238 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0006 |
| 239 |
PERSONALITY DISORDER |
1 |
0.0005 |
| 240 |
DYSMORPHISM |
1 |
0.0005 |
| 241 |
SKIN HYPERTROPHY |
1 |
0.0005 |
| 242 |
STARING |
1 |
0.0005 |
| 243 |
CLONUS |
1 |
0.0005 |
| 244 |
VITREOUS HAEMORRHAGE |
1 |
0.0005 |
| 245 |
BRUXISM |
2 |
0.0005 |
| 246 |
HEPATOSPLENOMEGALY |
1 |
0.0005 |
| 247 |
OSTEITIS |
1 |
0.0005 |
| 248 |
BLOOD SODIUM INCREASED |
1 |
0.0005 |
| 249 |
CYSTIC FIBROSIS |
2 |
0.0005 |
| 250 |
EYELID OEDEMA |
5 |
0.0005 |
| 251 |
INJECTION SITE PRURITUS |
23 |
0.0005 |
| 252 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
6 |
0.0005 |
| 253 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0005 |
| 254 |
NEPHRITIS |
1 |
0.0005 |
| 255 |
LIVER ABSCESS |
1 |
0.0005 |
| 256 |
THYROID MASS |
1 |
0.0005 |
| 257 |
PORTAL HYPERTENSION |
1 |
0.0005 |
| 258 |
DUODENITIS |
1 |
0.0005 |
| 259 |
DEAFNESS NEUROSENSORY |
1 |
0.0005 |
| 260 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0005 |
| 261 |
DIABETIC COMPLICATION |
1 |
0.0005 |
| 262 |
LUMBAR SPINAL STENOSIS |
1 |
0.0005 |
| 263 |
URINE ANALYSIS ABNORMAL |
1 |
0.0005 |
| 264 |
REGURGITATION |
1 |
0.0004 |
| 265 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 266 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0004 |
| 267 |
MALNUTRITION |
3 |
0.0004 |
| 268 |
SPINAL COLUMN STENOSIS |
2 |
0.0004 |
| 269 |
SOCIAL AVOIDANT BEHAVIOUR |
2 |
0.0004 |
| 270 |
B-CELL LYMPHOMA |
1 |
0.0004 |
| 271 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0004 |
| 272 |
CLAVICLE FRACTURE |
1 |
0.0004 |
| 273 |
TENSION HEADACHE |
1 |
0.0004 |
| 274 |
EAR INFECTION |
6 |
0.0004 |
| 275 |
EXCORIATION |
1 |
0.0004 |
| 276 |
HEREDITARY ANGIOEDEMA |
2 |
0.0004 |
| 277 |
BREAST ENLARGEMENT |
1 |
0.0004 |
| 278 |
VIRAL INFECTION |
8 |
0.0004 |
| 279 |
ABSCESS LIMB |
1 |
0.0004 |
| 280 |
BLOOD GLUCOSE FLUCTUATION |
3 |
0.0004 |
| 281 |
SPLENOMEGALY |
3 |
0.0004 |
| 282 |
NEEDLE ISSUE |
4 |
0.0004 |
| 283 |
GENERALISED OEDEMA |
3 |
0.0004 |
| 284 |
INJECTION SITE MASS |
8 |
0.0004 |
| 285 |
CRYING |
10 |
0.0004 |
| 286 |
GASTROENTERITIS VIRAL |
4 |
0.0004 |
| 287 |
GENERALISED ERYTHEMA |
2 |
0.0003 |
| 288 |
HEPATIC CIRRHOSIS |
4 |
0.0003 |
| 289 |
DISEASE COMPLICATION |
1 |
0.0003 |
| 290 |
HYPERTHYROIDISM |
3 |
0.0003 |
| 291 |
RETINAL DETACHMENT |
2 |
0.0003 |
| 292 |
INJECTION SITE IRRITATION |
3 |
0.0003 |
| 293 |
EXOSTOSIS |
2 |
0.0003 |
| 294 |
BLEPHAROSPASM |
1 |
0.0003 |
| 295 |
PROTEIN URINE PRESENT |
1 |
0.0003 |
| 296 |
TEMPERATURE INTOLERANCE |
2 |
0.0003 |
| 297 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0003 |
| 298 |
HYPERNATRAEMIA |
1 |
0.0003 |
| 299 |
TEARFULNESS |
1 |
0.0003 |
| 300 |
INCREASED TENDENCY TO BRUISE |
2 |
0.0003 |
| 301 |
GASTROENTERITIS |
3 |
0.0003 |
| 302 |
ENDOCARDITIS |
1 |
0.0003 |
| 303 |
MYELODYSPLASTIC SYNDROME |
3 |
0.0003 |
| 304 |
BACTERAEMIA |
2 |
0.0003 |
| 305 |
PALLOR |
5 |
0.0003 |
| 306 |
STREPTOCOCCAL INFECTION |
1 |
0.0003 |
| 307 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
| 308 |
MALABSORPTION |
1 |
0.0003 |
| 309 |
FOOT DEFORMITY |
2 |
0.0003 |
| 310 |
CACHEXIA |
1 |
0.0003 |
| 311 |
PERIORBITAL OEDEMA |
1 |
0.0003 |
| 312 |
INJECTION SITE SWELLING |
13 |
0.0003 |
| 313 |
APPETITE DISORDER |
1 |
0.0003 |
| 314 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0003 |
| 315 |
LIP SWELLING |
6 |
0.0003 |
| 316 |
NASAL CONGESTION |
9 |
0.0003 |
| 317 |
HYDROCEPHALUS |
1 |
0.0003 |
| 318 |
VENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 319 |
OSTEONECROSIS |
6 |
0.0003 |
| 320 |
AUTOIMMUNE DISORDER |
1 |
0.0003 |
| 321 |
INJECTION SITE ERYTHEMA |
22 |
0.0003 |
| 322 |
RESPIRATORY TRACT INFECTION |
4 |
0.0003 |
| 323 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0003 |
| 324 |
BLOOD GLUCOSE ABNORMAL |
3 |
0.0002 |
| 325 |
TIC |
1 |
0.0002 |
| 326 |
INJECTION SITE WARMTH |
4 |
0.0002 |
| 327 |
DIABETES MELLITUS INADEQUATE CONTROL |
3 |
0.0002 |
| 328 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 329 |
SKIN SWELLING |
1 |
0.0002 |
| 330 |
SICKLE CELL ANAEMIA WITH CRISIS |
1 |
0.0002 |
| 331 |
DRUG DOSE OMISSION |
40 |
0.0002 |
| 332 |
CLOSTRIDIUM DIFFICILE INFECTION |
3 |
0.0002 |
| 333 |
SUDDEN DEATH |
2 |
0.0002 |
| 334 |
INJECTION SITE BRUISING |
12 |
0.0002 |
| 335 |
ENERGY INCREASED |
1 |
0.0002 |
| 336 |
ENCEPHALITIS |
1 |
0.0002 |
| 337 |
DIPLOPIA |
4 |
0.0002 |
| 338 |
UNRESPONSIVE TO STIMULI |
4 |
0.0002 |
| 339 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0002 |
| 340 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0002 |
| 341 |
HAND FRACTURE |
1 |
0.0002 |
| 342 |
INJECTION SITE RASH |
4 |
0.0002 |
| 343 |
SINUS CONGESTION |
2 |
0.0002 |
| 344 |
SKIN REACTION |
2 |
0.0002 |
| 345 |
FEEDING DISORDER |
2 |
0.0002 |
| 346 |
ARTHROPOD BITE |
1 |
0.0002 |
| 347 |
EYE MOVEMENT DISORDER |
1 |
0.0002 |
| 348 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0002 |
| 349 |
FACIAL PARALYSIS |
1 |
0.0002 |
| 350 |
HYPOALBUMINAEMIA |
1 |
0.0002 |
| 351 |
EYE SWELLING |
5 |
0.0002 |
| 352 |
CONCUSSION |
1 |
0.0002 |
| 353 |
RESPIRATORY DISTRESS |
4 |
0.0002 |
| 354 |
SPINAL OPERATION |
1 |
0.0002 |
| 355 |
OFF LABEL USE |
76 |
0.0002 |
| 356 |
HYPERGLYCAEMIA |
5 |
0.0002 |
| 357 |
PSEUDOMONAS INFECTION |
1 |
0.0002 |
| 358 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 359 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0002 |
| 360 |
INJECTION SITE PAIN |
35 |
0.0002 |
| 361 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
14 |
0.0002 |
| 362 |
CARDIAC OPERATION |
1 |
0.0002 |
| 363 |
PSYCHIATRIC SYMPTOM |
1 |
0.0002 |
| 364 |
STOMACH DISCOMFORT |
1 |
0.0002 |
| 365 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 366 |
TENDON PAIN |
1 |
0.0002 |
| 367 |
SHOCK HAEMORRHAGIC |
1 |
0.0002 |
| 368 |
LEUKAEMIA |
1 |
0.0002 |
| 369 |
PRODUCT DOSE OMISSION |
13 |
0.0002 |
| 370 |
CARDIOMYOPATHY |
2 |
0.0002 |
| 371 |
MYOCARDITIS |
1 |
0.0002 |
| 372 |
HYPOPHAGIA |
3 |
0.0002 |
| 373 |
AGGRESSION |
7 |
0.0002 |
| 374 |
RHINORRHOEA |
7 |
0.0002 |
| 375 |
INJECTION SITE DISCOMFORT |
1 |
0.0002 |
| 376 |
DEAFNESS |
3 |
0.0002 |
| 377 |
SWELLING FACE |
8 |
0.0002 |
| 378 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 379 |
APPENDICITIS |
1 |
0.0002 |
| 380 |
PYELONEPHRITIS |
1 |
0.0002 |
| 381 |
CYANOSIS |
2 |
0.0002 |
| 382 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0002 |
| 383 |
MUSCLE STRAIN |
1 |
0.0002 |
| 384 |
ACCIDENTAL OVERDOSE |
4 |
0.0002 |
| 385 |
URTICARIA |
18 |
0.0002 |
| 386 |
ANGIOEDEMA |
5 |
0.0002 |
| 387 |
DECREASED ACTIVITY |
1 |
0.0002 |
| 388 |
APNOEA |
1 |
0.0002 |
| 389 |
NERVE COMPRESSION |
1 |
0.0002 |
| 390 |
SUBSTANCE ABUSE |
1 |
0.0002 |
| 391 |
LIGAMENT SPRAIN |
1 |
0.0002 |
| 392 |
CONGENITAL ANOMALY |
1 |
0.0002 |
| 393 |
MOOD SWINGS |
4 |
0.0002 |
| 394 |
FACE OEDEMA |
2 |
0.0002 |
| 395 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0002 |
| 396 |
FLANK PAIN |
1 |
0.0002 |
| 397 |
PROCEDURAL COMPLICATION |
1 |
0.0002 |
| 398 |
RESTLESS LEGS SYNDROME |
2 |
0.0002 |
| 399 |
BLOOD IRON DECREASED |
1 |
0.0002 |
| 400 |
TREATMENT NONCOMPLIANCE |
5 |
0.0002 |
| 401 |
EYE INFECTION |
1 |
0.0002 |
| 402 |
CONVULSION |
9 |
0.0002 |
| 403 |
FOOT FRACTURE |
2 |
0.0002 |
| 404 |
BRAIN INJURY |
1 |
0.0002 |
| 405 |
HAEMOLYTIC ANAEMIA |
1 |
0.0002 |
| 406 |
COELIAC DISEASE |
1 |
0.0002 |
| 407 |
POOR QUALITY SLEEP |
2 |
0.0002 |
| 408 |
SKIN INFECTION |
1 |
0.0002 |
| 409 |
EYELID PTOSIS |
1 |
0.0002 |
| 410 |
OPTIC NEURITIS |
1 |
0.0002 |
| 411 |
ERYTHEMA MULTIFORME |
1 |
0.0002 |
| 412 |
INJECTION SITE HAEMATOMA |
2 |
0.0002 |
| 413 |
INJECTION SITE HAEMORRHAGE |
7 |
0.0002 |
| 414 |
ABDOMINAL DISTENSION |
10 |
0.0001 |
| 415 |
GASTRIC ULCER |
2 |
0.0001 |
| 416 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 417 |
ASPIRATION |
1 |
0.0001 |
| 418 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 419 |
UPPER LIMB FRACTURE |
2 |
0.0001 |
| 420 |
FRACTURE |
2 |
0.0001 |
| 421 |
RETCHING |
2 |
0.0001 |
| 422 |
EATING DISORDER |
2 |
0.0001 |
| 423 |
DECREASED APPETITE |
20 |
0.0001 |
| 424 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 425 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 426 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 427 |
FEELING JITTERY |
2 |
0.0001 |
| 428 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 429 |
ATELECTASIS |
1 |
0.0001 |
| 430 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 431 |
HEADACHE |
57 |
0.0001 |
| 432 |
MICTURITION URGENCY |
1 |
0.0001 |
| 433 |
HEPATOMEGALY |
1 |
0.0001 |
| 434 |
HAIR DISORDER |
1 |
0.0001 |
| 435 |
OESOPHAGITIS |
1 |
0.0001 |
| 436 |
DISEASE RECURRENCE |
2 |
0.0001 |
| 437 |
SKIN DISCOLOURATION |
4 |
0.0001 |
| 438 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 439 |
HYPOACUSIS |
3 |
0.0001 |
| 440 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 441 |
DENTAL CARIES |
1 |
0.0001 |
| 442 |
VOMITING |
39 |
0.0001 |
| 443 |
WRIST FRACTURE |
1 |
0.0001 |
| 444 |
OVERDOSE |
15 |
0.0001 |
| 445 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 446 |
EYE PRURITUS |
2 |
0.0001 |
| 447 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 448 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 449 |
LETHARGY |
5 |
0.0001 |
| 450 |
DEPRESSED MOOD |
4 |
0.0001 |
| 451 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 452 |
RASH GENERALISED |
3 |
0.0001 |
| 453 |
HEPATITIS |
2 |
0.0001 |
| 454 |
PHARYNGITIS |
1 |
0.0001 |
| 455 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 456 |
PYREXIA |
26 |
0.0001 |
| 457 |
CONDITION AGGRAVATED |
18 |
0.0001 |
| 458 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 459 |
HYPERHIDROSIS |
10 |
0.0001 |
| 460 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 461 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 462 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 463 |
GYNAECOMASTIA |
3 |
0.0001 |
| 464 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 465 |
LACERATION |
1 |
0.0001 |
| 466 |
INJECTION SITE REACTION |
5 |
0.0001 |
| 467 |
LYMPHOMA |
1 |
0.0001 |
| 468 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 469 |
MASS |
1 |
0.0001 |
| 470 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 471 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 472 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 473 |
OBESITY |
1 |
0.0001 |
| 474 |
CONSTIPATION |
13 |
0.0001 |
| 475 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 476 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 477 |
EYE DISORDER |
2 |
0.0001 |
| 478 |
ANKLE FRACTURE |
1 |
0.0001 |
| 479 |
SOMNOLENCE |
13 |
0.0001 |
| 480 |
HEPATIC FAILURE |
2 |
0.0001 |
| 481 |
ABDOMINAL PAIN |
14 |
0.0001 |
| 482 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0001 |
| 483 |
ORAL HERPES |
1 |
0.0001 |
| 484 |
IRRITABILITY |
4 |
0.0001 |
| 485 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 486 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 487 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 488 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0001 |
| 489 |
DEHYDRATION |
8 |
0.0001 |
| 490 |
HERNIA |
1 |
0.0001 |
| 491 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
3 |
0.0001 |
| 492 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 493 |
DERMATITIS |
1 |
0.0001 |
| 494 |
SPEECH DISORDER |
3 |
0.0001 |
| 495 |
NECK PAIN |
3 |
0.0001 |
| 496 |
SEIZURE |
5 |
0.0001 |
| 497 |
HAEMATURIA |
2 |
0.0001 |
| 498 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 499 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0001 |
| 500 |
GLAUCOMA |
1 |
0.0001 |
| 501 |
HEPATOTOXICITY |
1 |
0.0001 |
| 502 |
SINUSITIS |
5 |
0.0001 |
| 503 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0001 |
| 504 |
WOUND |
1 |
0.0001 |
| 505 |
MOUTH ULCERATION |
1 |
0.0001 |
| 506 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 507 |
SNEEZING |
1 |
0.0001 |
| 508 |
NERVOUSNESS |
3 |
0.0001 |
| 509 |
BRONCHITIS |
4 |
0.0001 |
| 510 |
INFLUENZA |
5 |
0.0001 |
| 511 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 512 |
BODY TEMPERATURE INCREASED |
1 |
0.0001 |
| 513 |
LIVER DISORDER |
2 |
0.0001 |
| 514 |
INTENTIONAL SELF-INJURY |
1 |
0.0001 |
| 515 |
MIGRAINE |
4 |
0.0001 |
| 516 |
TREMOR |
8 |
0.0001 |
| 517 |
PERICARDIAL EFFUSION |
1 |
0.0001 |
| 518 |
NEURALGIA |
1 |
0.0001 |
| 519 |
MALAISE |
21 |
0.0001 |
| 520 |
PNEUMONIA |
14 |
0.0001 |
| 521 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0001 |
| 522 |
LOSS OF CONSCIOUSNESS |
6 |
0.0001 |
| 523 |
SEPSIS |
5 |
0.0001 |
| 524 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 525 |
PNEUMONITIS |
1 |
0.0001 |
| 526 |
ENCEPHALOPATHY |
1 |
0.0001 |
| 527 |
OEDEMA PERIPHERAL |
6 |
0.0001 |
| 528 |
UNDERDOSE |
3 |
0.0001 |
| 529 |
DIABETIC KETOACIDOSIS |
1 |
0.0001 |
| 530 |
ANAPHYLACTIC REACTION |
2 |
0.0001 |
| 531 |
PNEUMONIA ASPIRATION |
1 |
0.0001 |
| 532 |
NASOPHARYNGITIS |
7 |
0.0001 |
| 533 |
CHROMATURIA |
1 |
0.0001 |
| 534 |
FATIGUE |
29 |
0.0001 |
| 535 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0001 |
| 536 |
DEPRESSION |
10 |
0.0001 |
| 537 |
BACK PAIN |
9 |
0.0001 |
| 538 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 539 |
PRODUCT USE ISSUE |
6 |
0.0001 |
| 540 |
HAEMOGLOBIN DECREASED |
4 |
0.0001 |
| 541 |
BONE MARROW FAILURE |
1 |
0.0001 |
| 542 |
ABDOMINAL PAIN LOWER |
1 |
0.0001 |
| 543 |
OEDEMA |
2 |
0.0001 |
| 544 |
GASTRITIS |
1 |
0.0001 |
| 545 |
PAIN IN EXTREMITY |
11 |
0.0001 |
| 546 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0001 |
| 547 |
SWELLING |
3 |
0.0001 |
| 548 |
EPILEPSY |
1 |
0.0001 |
| 549 |
COUGH |
9 |
0.0001 |
| 550 |
LABORATORY TEST ABNORMAL |
1 |
0.0001 |
| 551 |
HYPERSOMNIA |
1 |
0.0001 |
| 552 |
ALOPECIA |
7 |
0.0001 |
| 553 |
ASTHMA |
3 |
0.0001 |
| 554 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 555 |
SKIN DISORDER |
1 |
0.0001 |
| 556 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
5 |
0.0001 |
| 557 |
ASCITES |
1 |
0.0001 |
| 558 |
HEPATIC ENZYME INCREASED |
2 |
0.0001 |
| 559 |
RESPIRATORY DISORDER |
1 |
0.0001 |
| 560 |
BONE PAIN |
2 |
0.0001 |
| 561 |
SLEEP DISORDER |
2 |
0.0000 |
| 562 |
ARTHRALGIA |
12 |
0.0000 |
| 563 |
FEELING HOT |
2 |
0.0000 |
| 564 |
HEAD INJURY |
1 |
0.0000 |
| 565 |
ADVERSE EVENT |
3 |
0.0000 |
| 566 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 567 |
COLITIS |
1 |
0.0000 |
| 568 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 569 |
ANXIETY |
9 |
0.0000 |
| 570 |
FEAR |
1 |
0.0000 |
| 571 |
HYPOXIA |
1 |
0.0000 |
| 572 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 573 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 574 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 575 |
HOT FLUSH |
2 |
0.0000 |
| 576 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 577 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 578 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 579 |
TREATMENT FAILURE |
2 |
0.0000 |
| 580 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 581 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 582 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 583 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 584 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 585 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 586 |
RESTLESSNESS |
1 |
0.0000 |
| 587 |
DIZZINESS |
13 |
0.0000 |
| 588 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 589 |
DYSURIA |
1 |
0.0000 |
| 590 |
ANGER |
1 |
0.0000 |
| 591 |
NAUSEA |
20 |
0.0000 |
| 592 |
EPISTAXIS |
2 |
0.0000 |
| 593 |
CARDIAC FAILURE |
2 |
0.0000 |
| 594 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 595 |
ACNE |
2 |
0.0000 |
| 596 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 597 |
PARAESTHESIA |
4 |
0.0000 |
| 598 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 599 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 600 |
ERYTHEMA |
5 |
0.0000 |
| 601 |
AGITATION |
2 |
0.0000 |
| 602 |
MENTAL DISORDER |
1 |
0.0000 |
| 603 |
INFLAMMATION |
1 |
0.0000 |
| 604 |
DYSKINESIA |
1 |
0.0000 |
| 605 |
FEELING ABNORMAL |
6 |
0.0000 |
| 606 |
WEIGHT INCREASED |
5 |
0.0000 |
| 607 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 608 |
RASH |
9 |
0.0000 |
| 609 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 610 |
WEIGHT DECREASED |
6 |
0.0000 |
| 611 |
PRURITUS |
7 |
0.0000 |
| 612 |
VISION BLURRED |
3 |
0.0000 |
| 613 |
EYE IRRITATION |
1 |
0.0000 |
| 614 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 615 |
DISCOMFORT |
1 |
0.0000 |
| 616 |
LUNG DISORDER |
1 |
0.0000 |
| 617 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 618 |
ASTHENIA |
8 |
0.0000 |
| 619 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 620 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 621 |
TINNITUS |
1 |
0.0000 |
| 622 |
EYE PAIN |
1 |
0.0000 |
| 623 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 624 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 625 |
ANAEMIA |
4 |
0.0000 |
| 626 |
LEUKOPENIA |
1 |
0.0000 |
| 627 |
CHEST PAIN |
4 |
0.0000 |
| 628 |
COMA |
1 |
0.0000 |
| 629 |
RASH PRURITIC |
1 |
0.0000 |
| 630 |
HYPOAESTHESIA |
3 |
0.0000 |
| 631 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 632 |
FLUID RETENTION |
1 |
0.0000 |
| 633 |
CELLULITIS |
1 |
0.0000 |
| 634 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 635 |
CATARACT |
1 |
0.0000 |
| 636 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 637 |
DIARRHOEA |
11 |
0.0000 |
| 638 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 639 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 640 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 641 |
DYSPHONIA |
1 |
0.0000 |
| 642 |
DYSPNOEA |
10 |
0.0000 |
| 643 |
PANCREATITIS |
1 |
0.0000 |
| 644 |
DRY SKIN |
2 |
0.0000 |
| 645 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 646 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 647 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 648 |
MEDICATION ERROR |
1 |
0.0000 |
| 649 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 650 |
STRESS |
1 |
0.0000 |
| 651 |
DRUG INEFFECTIVE |
18 |
0.0000 |
| 652 |
DRUG HYPERSENSITIVITY |
3 |
0.0000 |
| 653 |
ARTHRITIS |
1 |
0.0000 |
| 654 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 655 |
PAIN |
7 |
0.0000 |
| 656 |
DYSGEUSIA |
1 |
0.0000 |
| 657 |
DRUG ABUSE |
1 |
0.0000 |
| 658 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 659 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 660 |
DRUG INTERACTION |
2 |
0.0000 |
| 661 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 662 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 663 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 664 |
TACHYCARDIA |
1 |
0.0000 |
| 665 |
CARDIAC ARREST |
1 |
0.0000 |
| 666 |
CONTUSION |
1 |
0.0000 |
| 667 |
DYSPEPSIA |
1 |
0.0000 |
| 668 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 669 |
CARDIAC DISORDER |
1 |
0.0000 |
| 670 |
HEART RATE INCREASED |
1 |
0.0000 |
| 671 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 672 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 673 |
SYNCOPE |
1 |
0.0000 |
| 674 |
FALL |
3 |
0.0000 |
| 675 |
PALPITATIONS |
1 |
0.0000 |
| 676 |
HOSPITALISATION |
1 |
0.0000 |
| 677 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 678 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 679 |
RENAL FAILURE |
1 |
0.0000 |
| 680 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 681 |
DEATH |
5 |
0.0000 |
| 682 |
MYALGIA |
1 |
0.0000 |
| 683 |
MUSCLE SPASMS |
1 |
0.0000 |
| 684 |
HYPOTENSION |
1 |
0.0000 |
| 685 |
INSOMNIA |
1 |
0.0000 |